CompanyDrug

Beijing Konruns Pharmaceutical Launches Phase III Study for KC1036 in Advanced Esophageal Cancer

CompanyDrug

Lee’s Pharmaceutical Secures NMPA Approval for Adasuve, Pioneering Loxapine Inhaler for Agitation

CompanyMedical Device

AK Medical Holdings Receives NMPA Approval for Hip Surgery Navigation System iBot

CompanyDrug

Gracell Biotechnologies Gets FDA Green Light for FasTCAR-T Therapy in Systemic Lupus Erythematosus

CompanyDeals

Mabwell Bioscience Enters Thai Market with Licensing Deal with Innobic

CompanyDeals

Taihe Weiye Biotechnology Secures RMB 300 Million in Series A+ Financing to Expand Production

CompanyDrug

Dupixent Trial Success Reinforces Potential in Moderate-to-Severe COPD Treatment

CompanyDrug

AbbVie’s Epcoritamab Earns EMA Review and FDA Breakthrough Designation for Follicular Lymphoma

CompanyR&D

AstraZeneca to Open R&D Center in Hong Kong, Focusing on Cell and Gene Therapies

Company

Bayer Faces Backlash After Bond Sale Preceding Late-Stage Pipeline Failure

CompanyDrug

Everest Medicines’ Nefecon for IgAN Receives NMPA Approval in China

CompanyDeals

Beijing QL Biopharmaceutical Boosts Pipeline with RMB 200 Million Series B+ Round